These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 21548140)

  • 1. Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).
    Wood DM; Brailsford AD; Dargan PI
    Drug Test Anal; 2011; 3(7-8):417-25. PubMed ID: 21548140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate.
    Palmer RB
    Toxicol Rev; 2004; 23(1):21-31. PubMed ID: 15298490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of equimolar doses of gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4-BD) and gamma-butyrolactone (GBL) on catalepsy after acute and chronic administration.
    Towiwat P; Phattanarudee S; Maher TJ
    Food Chem Toxicol; 2013 Jan; 51():337-42. PubMed ID: 23104245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
    Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI
    QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review.
    Wojtowicz JM; Yarema MC; Wax PM
    CJEM; 2008 Jan; 10(1):69-74. PubMed ID: 18226321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
    Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
    Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current knowledge on gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL) and 1 ,4-butanediol (1,4-BD)].
    Dematteis M; Pennel L; Mallaret M
    Rev Prat; 2012 May; 62(5):669-72. PubMed ID: 22730800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4BD), and gamma-butyrolactone (GBL) intoxication: A state-of-the-art review.
    Dufayet L; Bargel S; Bonnet A; Boukerma AK; Chevallier C; Evrard M; Guillotin S; Loeuillet E; Paradis C; Pouget AM; Reynoard J; Vaucel JA
    Regul Toxicol Pharmacol; 2023 Aug; 142():105435. PubMed ID: 37343712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-Hydroxybutyrate (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion.
    Sadasivan S; Maher TJ; Quang LS
    Ann N Y Acad Sci; 2006 Aug; 1074():537-44. PubMed ID: 17105951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.
    Goodwin AK; Brown PR; Jansen EE; Jakobs C; Gibson KM; Weerts EM
    Psychopharmacology (Berl); 2009 Jun; 204(3):465-76. PubMed ID: 19198808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of γ-hydroxybutyrate (GHB), β-hydroxybutyrate (BHB), pregabalin, 1,4-butane-diol (1,4BD) and γ-butyrolactone (GBL) in whole blood and urine samples by UPLC-MSMS.
    Dahl SR; Olsen KM; Strand DH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():37-42. PubMed ID: 22226469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use.
    Corkery JM; Loi B; Claridge H; Goodair C; Corazza O; Elliott S; Schifano F
    Neurosci Biobehav Rev; 2015 Jun; 53():52-78. PubMed ID: 25843781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.
    Busardò FP; Jones AW
    Curr Neuropharmacol; 2015 Jan; 13(1):47-70. PubMed ID: 26074743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
    Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
    CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacing GHB with GBL in Recreational Settings: A New Trend in Chemsex.
    Busardò FP; Gottardi M; Tini A; Minutillo A; Sirignano A; Marinelli E; Zaami S
    Curr Drug Metab; 2018; 19(13):1080-1085. PubMed ID: 30251602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and its metabolic precursor, gamma-butyrolactone (GBL) in rats.
    Baker LE; Van Tilburg TJ; Brandt AE; Poling A
    Psychopharmacology (Berl); 2005 Sep; 181(3):458-66. PubMed ID: 16001124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
    Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
    Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of 1,4-Butanediol Misuse: A Review.
    Skryabin V; Shevtsova Y; Novoselova EA
    Psychopharmacol Bull; 2023 Dec; 53(4):48-53. PubMed ID: 38076667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans.
    Bosch OG; Seifritz E
    Brain Res Bull; 2016 Sep; 126(Pt 1):47-60. PubMed ID: 26855327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom Communities Associated with GHB and Precursors.
    Corkery JM; Loi B; Claridge H; Goodair C; Schifano F
    Curr Drug Metab; 2018; 19(13):1086-1099. PubMed ID: 29119924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.